The largest database of trusted experimental protocols

Ribolock rnase inhibitor

Manufactured by Merck Group

RiboLock RNase Inhibitor is a recombinant ribonuclease (RNase) inhibitor protein that binds to and inhibits the activity of RNase enzymes. It is designed to protect RNA samples from degradation during various molecular biology applications.

Automatically generated - may contain errors

2 protocols using ribolock rnase inhibitor

1

Synthesis of UBE3C-LRP5 siRNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sense and anti-sense DNA oligonucleotides for UBE3C-LRP5 fusion variants (v1, v2, and v7), LRP5, CTNNB1, LEF1, and scrambled siRNA (Supplementary Table S5) were ordered from Sigma-Aldrich. The protocol for the synthesis of small RNA transcripts using T7 RNA polymerase is reported in the literature69 (link). For each in vitro transcription (IVT) reaction, 1 nmol of each oligonucleotide (re-suspended in 1X TE buffer (10 mM Tris-HCl pH 8.0 and 1 mM EDTA)) was annealed using thermocycler to obtain double-stranded DNA (dsDNA). The thermocycler conditions used were: 95 °C for 3 min, followed by 70 cycles of 95 °C for 30 s (−1 °C/cycle). In vitro transcription (IVT) reaction was performed in 20 µL of a reaction containing 1X T7 transcription buffer (cat. no. P118B, Promega), 1X biotin RNA labeling mix (cat. no. 11685597910, Sigma-Aldrich), 1 U RiboLock RNase Inhibitor (cat. no. EO0381, Fermentas), 10 U T7 RNA polymerase (cat. no. P2075, Promega), and 1 nmol of dsDNA, as a template. The reaction was incubated at 37 °C for 2 h. Sense and anti-sense small interfering RNA (siRNA) synthesized in separate reactions were annealed by mixing the transcription reactions at 95 °C for 1 min, followed by 70 cycles of 95 °C for 30 s (−1 °C/cycle) to obtain double-stranded siRNAs.
+ Open protocol
+ Expand
2

Mapping Antibiotic-Binding Sites in Bacterial Ribosomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
rRNA probing was performed following published protocols (19 ) with minor modifications. Briefly, E. coli or S. aureus ribosomes were dissolved at 200 nM concentration in 50 μl of buffer B (400 mM HEPES-KOH, pH 7.8, 50 mM MgCl2, 500 mM NH4Cl) supplemented with 20 U of Ribolock RNase inhibitor (40 U/μl, Sigma). After addition of 2 μl of the antibiotic solution (or of ethanol in the ‘no drug’ control reactions), samples were incubated at 37°C for 10 min, followed by additional 10 min at 20°C. Antibiotics were present at the final concentration of 50 μM. After antibiotic binding, dimethylsulfate (DMS) was added and tubes were incubated for 10 min at 37°C. The reactions were quenched with β-mercaptoethanol, ribosomes were ethanol-precipitated and rRNA was extracted. Modifications of the E. coli 23S rRNA nucleotides in the PTC and NPET were assessed by primer extension using the primers L2081 (GGGTGGTATTTCAAGGTCGG), L2563 (TCGCGTACCACTTTA), L2667 (GGTCCTCTCGTACTAGGAGCAG) or L2750 (CAAGTTTCGTGCTTAGATGC). The primer SaL2230 (TAGTATCCCACCAGCGTCTC) was used in experiments with S. aureus ribosomes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!